4//SEC Filing
Wyrick Susan D. 4
Accession 0001562180-25-001888
CIK 0001770121other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:28 PM ET
Size
9.0 KB
Accession
0001562180-25-001888
Insider Transaction Report
Form 4
Wyrick Susan D.
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2025-03-02+1,525→ 155,471 total - Exercise/Conversion
Restricted Stock Units
2025-03-02−1,525→ 3,050 total→ Common Stock (1,525 underlying) - Tax Payment
Common Stock
2025-03-03$2.56/sh−490$1,254→ 154,981 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
- [F2]The award vested as to 25% of the restricted stock units on each of March 2, 2024 and 2025, and the remaining restricted stock units vest in two equal installments on each of March 2, 2026 and 2027, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
Documents
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001568605
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:28 PM ET
- Size
- 9.0 KB